Earnings preview

Moderna, Inc. Moderna, Inc. Q2 2026 Earnings Results vs. Expectations

ReportsJul 31, 2026
SlotTime Not Announced

Results are out

This quarter has reported. The consensus below is what we expected going in.

Read the release →

What the Street expects

EPS
-$1.97
consensus · see the release
QoQ−66.9%
YoY—
Revenue
$126.7M
consensus · see the release
QoQ—
YoY—

QoQ and YoY are what the consensus implies against the prior quarter and the prior year.

Also on the card
Reported equals consensus −$1.97, in line

Q2 2026 reported results

Estimate against reported

$0.54−$1.69−$3.912024 Q3 reported $0.032024 Q32024 Q4 reported −$2.912024 Q42025 Q1 reported −$2.522025 Q12025 Q2 reported −$2.132025 Q22025 Q3 reported −$0.512025 Q32025 Q4 reported −$2.112025 Q42026 Q1 reported −$3.402026 Q12026 Q2 estimate −$1.972026 Q2 reported −$1.972026 Q2
Our published estimate Reported EPS
QuarterEstimateReportedSurprise
2024 Q3 — $0.03 —
2024 Q4 — −$2.91 —
2025 Q1 — −$2.52 —
2025 Q2 — −$2.13 —
2025 Q3 — −$0.51 —
2025 Q4 — −$2.11 —
2026 Q1 — −$3.40 —
2026 Q2 −$1.97 −$1.97 0%

Estimates are the consensus we published on our own preview for that quarter; quarters we did not preview carry the reported figure only. Where a consensus was set on a non-GAAP basis, the reported column shows that same measure.

Every quarter

Q2 2026 release page View MRNA stock page